Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Immune Intervention Reduces β-Cell Death in Type 1 Diabetes
Improvement in C-peptide responses seen with teplizumab; associated with decreased β-cell death
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

April 20, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Suboptimal Prescribing Attitudes Could Signal Personal Distress

Apple HealthKit App Facilitates Doctor-Patient Communication

Prolonged ADT Ups Diabetes, CVD Risk for Older Men

Fish Oil Supplementation Tied to Lower Atherothrombotic Risk

Ethical Implications for Looking Up Applicants on Facebook

Medicare Spending Down in Year One of Pioneer ACO